Clinical Trial Update: Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating succinylated gelatin to prevent fluid retention in patients with breast cancer receiving docetaxel chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Fluid Retention

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Succinylated Gelatin (succinylated gelatin)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Fluid Retention | Phase 2 | Status: COMPLETED